Surface Oncology

Surface Oncology was created to advance next-generation approaches to cancer immunotherapy based on proprietary insights about novel immunotherapy targets and emerging areas of cancer immuno-biology. Together with world-leading scientific founders, the Company is advancing multiple preclinical programs that target novel mechanisms shown to play vital roles in tumor immune-evasion. Surface is based in Cambridge, Mass.
Company growth
Type
Private
HQ
Cambridge, US
Founded
2014
Size (employees)
29 (est)+4%
Surface Oncology was founded in 2014 and is headquartered in Cambridge, US

Surface Oncology Office Locations

Surface Oncology has office in Cambridge
Cambridge, US

Surface Oncology Metrics

Surface Oncology Summary

Founding Date

2014

Total Funding

$35 M

Latest funding size

$35 M

Time since last funding

about 2 years

Investors

We estimate that Surface Oncology's latest funding round in January 2015 was $35 M. In total, Surface Oncology has raised $35 M
We estimate that Surface Oncology's current employees are approximately 40% female and 60% male.

Surface Oncology News

Surface Oncology Company Life

You may also be interested in